Eptifibatide (Medsurge) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: eptifibatide
Pack: Eptifibatide (Medsurge) 75 mg/100 mL injection, 100 mL vial
Brand name
(ARTG)
: EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 75 mg/100 mL solution for injection vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
EPTIFIBATIDE MEDSURGE is indicated for patients undergoing nonurgent percutaneous coronary intervention with intracoronary stenting (see Section 5.1 Pharmacodynamic Properties, Clinical trials). EPTIFIBATIDE MEDSURGE is indicated for the treatment of patients with unstable angina or non-Q-wave myocardial infarction (see Section 5.1 Pharmacodynamic Properties, Clinical trials).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear, colorless solution. Practically free from visible particles.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eptifibatide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
